diseases of the meninges (bacterial meningitis) as well as the lungs (bacterial pneumonia). Inflammations of the middle ear (otitis media) and the paranasal sinuses (sinusitis) are often caused by this pathogen.

Infection takes place by droplet infection. The treatment of pneumococcal diseases is complicated on account of the worldwide increase in antibiotic resistance. In many healthy people, the pathogen is present in the area of the nasopharynx. The risk of disease of the germ carrier itself or of other persons, who can be infected by it, depends on the respective defenses of the individual. The vaccination against pneumococcus is therefore indicated for specific population groups.

Pneumococcus Vaccination: Up to the age of 2 years: Pneumococcus conjugate vaccine, from the age of 2: polysaccharide vaccines.

Who should vaccinate?

  • All children up to the age of 24 months
  • Persons over 60 years of age
  • persons with increased health risks as a result of a basic condition – such as chronic lung-, or cardiovascular disease, diabetes, weakening of the immune system, condition after removal of the spleen
  • Children from the 2nd month of age with certain basic diseases or chronic illnesses

Time of vaccination:
In infancy from the 2nd month of age.
Three vaccinations at intervals of at least 4 weeks. Completion of the primary immunisation with the fourth vaccination after 11 months to 14 months of age. The pneumococcal vaccination should be carried out as soon as possible.
In adulthood from the age of 60 years, a vaccination (polysaccharide vaccine) and re-vaccination at intervals of 6 years.

In high-risk individuals, booster doses at least every 3 years for children under 10 years, then every 6 years.

Frequent vaccination reactions:
The vaccine, which has been available in Germany for children under 2 years of age since July 2001 has already been on the market in the USA for some time and has shown good tolerability.